120 related articles for article (PubMed ID: 11675903)
1. Expression of p73 in colorectal carcinoma: clinicopathological relevance.
Liu L; Cui X; Sakaguchi T; Sasaki M; Suda T; Hatakeyama K
J Int Med Res; 2001; 29(4):297-303. PubMed ID: 11675903
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients.
Toumi AA; El Hadj Oel A; Ben Mahmoud LK; Ben Hmida Ael M; Chaar I; Gharbi L; Mzabi S; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):128-36. PubMed ID: 19956069
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the p73 gene in relation to colorectal cancer risk and survival.
Pfeifer D; Arbman G; Sun XF
Carcinogenesis; 2005 Jan; 26(1):103-7. PubMed ID: 15485994
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.
Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M
Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743
[TBL] [Abstract][Full Text] [Related]
5. Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients.
Arfaoui AT; Kriaa LB; El Hadj Oel A; Ben Hmida MA; Khiari M; Khalfallah T; Gharbi L; Mzabi S; Bouraoui S
Virchows Arch; 2010 Sep; 457(3):359-68. PubMed ID: 20644956
[TBL] [Abstract][Full Text] [Related]
6. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma.
Sun XF
Clin Cancer Res; 2002 Jan; 8(1):165-70. PubMed ID: 11801554
[TBL] [Abstract][Full Text] [Related]
7. p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival.
Lee KE; Hong YS; Kim BG; Kim NY; Lee KM; Kwak JY; Roh MS
World J Gastroenterol; 2010 Sep; 16(35):4448-54. PubMed ID: 20845513
[TBL] [Abstract][Full Text] [Related]
8. p73 expression and its clinical significance in colorectal cancer.
Su XL; Ouyang XH; Yan MR; Liu GR
Colorectal Dis; 2009 Nov; 11(9):960-3. PubMed ID: 19016816
[TBL] [Abstract][Full Text] [Related]
9. p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
Díaz R; Peña C; Silva J; Lorenzo Y; García V; García JM; Sánchez A; Espinosa P; Yuste R; Bonilla F; Domínguez G
Int J Cancer; 2008 Sep; 123(5):1060-7. PubMed ID: 18546269
[TBL] [Abstract][Full Text] [Related]
10. p73 Overexpression and angiogenesis in human colorectal carcinoma.
Guan M; Peng HX; Yu B; Lu Y
Jpn J Clin Oncol; 2003 May; 33(5):215-20. PubMed ID: 12865464
[TBL] [Abstract][Full Text] [Related]
11. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma.
Tannapfel A; Wasner M; Krause K; Geissler F; Katalinic A; Hauss J; Mössner J; Engeland K; Wittekind C
J Natl Cancer Inst; 1999 Jul; 91(13):1154-8. PubMed ID: 10393724
[TBL] [Abstract][Full Text] [Related]
12. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
[TBL] [Abstract][Full Text] [Related]
13. Relationship between p73 polymorphism and the immunohistochemical profile of the full-length (TAp73) and NH2-truncated (ΔNp73) isoforms in Tunisian patients.
Arfaoui AT; Ben Mahmoud LK; Ben Hmida A; Khiari M; Mohamed AL; Chaar I; Khalfallah T; Regaya SM; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):546-54. PubMed ID: 20733477
[TBL] [Abstract][Full Text] [Related]
14. [Study progress of p73 gene in digestive system carcinoma].
Xin T; Fang LP
Ai Zheng; 2004 Jan; 23(1):95-8. PubMed ID: 14720384
[TBL] [Abstract][Full Text] [Related]
15. p73 and p53 pathway in human breast cancers.
Bozzetti C; Nizzoli R; Musolino A; Martella EM; Crafa P; Lagrasta CA; Camisa R; Bonati A; Lunghi P; Ardizzoni A
J Clin Oncol; 2007 Apr; 25(11):1451-3; author reply 1453-4. PubMed ID: 17416871
[No Abstract] [Full Text] [Related]
16. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
17. [P73 gene expression in colorectal adenocarcinoma: a prognostic or etiopathogenetic factor?].
Ben Mahmoud LK; Toumi AA; Chaâr I; Lahmer A; Khalfallah T; Mzabi SR; Bouraoui S
Tunis Med; 2009 Apr; 87(4):267-72. PubMed ID: 19835284
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
[TBL] [Abstract][Full Text] [Related]
19. The expression of p73 is increased in lung cancer, independent of p53 gene alteration.
Tokuchi Y; Hashimoto T; Kobayashi Y; Hayashi M; Nishida K; Hayashi S; Imai K; Nakachi K; Ishikawa Y; Nakagawa K; Kawakami Y; Tsuchiya E
Br J Cancer; 1999 Jul; 80(10):1623-9. PubMed ID: 10408409
[TBL] [Abstract][Full Text] [Related]
20. Relationship between expression of P27, Fragile Histidine Triad (FHT), phosphatase and tensin homolog deleted on chromosome ten (PTEN), P73, and prognosis in esophageal squamous cell carcinoma.
Chen Y; Wang X; Li F; Zhang L; Ma L; Liu Y
Ann Diagn Pathol; 2015 Feb; 19(1):33-6. PubMed ID: 25622532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]